Drug Shortage Report for TEVA-SILDENAFIL R

Last updated on 2021-01-21 History
Report ID 122442
Drug Identification Number 02319500
Brand name TEVA-SILDENAFIL R
Common or Proper name TEVA-SILDENAFIL R 20MG COATED TABS
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) SILDENAFIL
Strength(s) 20MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100
ATC code C02KX
ATC description OTHER ANTIHYPERTENSIVES
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2020-08-18
Estimated end date 2021-03-31
Actual end date
Shortage status Actual shortage
Updated date 2021-01-21
Company comments Will be allocating to 100% of Teva Market.
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2021-01-21 French Compare
v8 2021-01-21 English Compare
v7 2021-01-14 French Compare
v6 2021-01-14 English Compare
v5 2020-09-22 French Compare
v4 2020-09-22 English Compare
v3 2020-08-19 English Compare
v2 2020-08-18 French Compare
v1 2020-08-18 English Compare